Sponsor content
319 result(s) found, displaying 201 to 210
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TE-DASATINIB dasatinib 50 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DASATINIB-TEVA dasatinib 70 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DASATINIB-TEVA dasatinib 20 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DASATINIB-TEVA dasatinib 100 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TE-DASATINIB dasatinib 100 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OCTREOTIDE DEPOT octreotide (as acetate) 20 mg modified release injection vial plus diluent prefilled syringe composite pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OCTREOTIDE DEPOT octreotide (as acetate) 10 mg modified release injection vial plus diluent prefilled syringe composite pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OCTREOTIDE DEPOT octreotide (as acetate) 30 mg modified release injection vial plus diluent prefilled syringe composite pack.
-
Cancellation by sponsorRequested by Teva Pharma Australia Pty Ltd
-
Australian public assessment report (AusPar)AUSTEDO (deutetrabenazine) for the treatment of chorea associated with Huntington's disease and tardive dyskinesia in adult.